. Author manuscript; available in PMC: 2014 Jul 18.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 May 10;12(5):341–344. doi: 10.1016/j.clml.2012.04.001

Table 1. Patient Characteristic at Presentation (N = 27).

Characteristic	Median (Range or %)
Age, Years	64 (39-88)
Hemoglobin g/dL	9.3 (7.8-11.6)
Leukocyte Count, 10⁹/L	2.1 (1.8-6.4)
Platelet Count, 10⁹/L	26 (2-378)
BM Blast %	20 (2-72)
Female	13 (52%)
ECOG Status
0	5 (18.5%)
1	17 (63.0%)
2	5 (18.5%)
Diagnosis
AML	18 (67%)
MDS	9 (33%)
Cytogenetic Category
Complex	24 (89%)
5q and 1 Additional Abnormality	3 (11%)
Number of Previous Therapies	2 (0-6)
Previous Therapy
High Dose Cytarabine	12 (44%)
Hypomethylating Agent	9 (33%)
Clofarabine	1 (4%)
Untreated	5 (19%)

Abbreviations: AML = acute myeloid leukemia; BM = bone marrow; ECOG = Eastern Cooperative Oncology Group; MDS, myelodysplastic syndromes.